论文标题
分析SARS-COV-2变体对呼吸声信号的影响
Analyzing the impact of SARS-CoV-2 variants on respiratory sound signals
论文作者
论文摘要
COVID-19爆发导致多种与不同的SARS-COV-2变体相关的感染波。研究报告了这种变体对患者呼吸健康的影响不同。我们探讨了从COVID-19受试者收集的声学信号是否显示出可区分的声学模式,这表明有可能预测潜在的病毒变体。我们分析了从三个受试者库中收集的COSWARA数据集,即i)健康,ii)covid-19 covid-19在三角变体占主导地位期间记录的受试者,以及iii)III)来自Omicron Exprage期间COVID-19的数据。我们的发现表明,咳嗽,呼吸和语音等多种声音类别表明,在将COVID-19与Omicron和Delta变体进行比较时,声音特征差异很大。在曲线下,分类区域大大超过了被Omicron感染的受试者与被三角洲感染者区分开的机会。使用来自多个声音类别的得分融合,我们在95%的特异性下获得了89%和52.4%的敏感性的区域。此外,使用分层的三类方法将声学数据分类为健康和共同的-19阳性,并将进一步的COVID受试者分为Delta和Omicron变体,从而提供高水平的3类分类精度。这些结果提出了设计基于声音的Covid-19诊断方法的新方法。
The COVID-19 outbreak resulted in multiple waves of infections that have been associated with different SARS-CoV-2 variants. Studies have reported differential impact of the variants on respiratory health of patients. We explore whether acoustic signals, collected from COVID-19 subjects, show computationally distinguishable acoustic patterns suggesting a possibility to predict the underlying virus variant. We analyze the Coswara dataset which is collected from three subject pools, namely, i) healthy, ii) COVID-19 subjects recorded during the delta variant dominant period, and iii) data from COVID-19 subjects recorded during the omicron surge. Our findings suggest that multiple sound categories, such as cough, breathing, and speech, indicate significant acoustic feature differences when comparing COVID-19 subjects with omicron and delta variants. The classification areas-under-the-curve are significantly above chance for differentiating subjects infected by omicron from those infected by delta. Using a score fusion from multiple sound categories, we obtained an area-under-the-curve of 89% and 52.4% sensitivity at 95% specificity. Additionally, a hierarchical three class approach was used to classify the acoustic data into healthy and COVID-19 positive, and further COVID-19 subjects into delta and omicron variants providing high level of 3-class classification accuracy. These results suggest new ways for designing sound based COVID-19 diagnosis approaches.